VERAXA Biotech AG Appoints Christoph Erkel as Chief Scientific Officer
PUBLIC · VRXAJul 23, 2026
Position
Chief Scientific Officer
Company
VERAXA Biotech
Christoph Erkel
ZurichBiotechnologyHealth Care
Description
VERAXA Biotech AG announces the appointment of Christoph Erkel, Ph.D., as Chief Scientific Officer, effective immediately. He succeeds Rick Austin, Ph.D., who is leaving the company after a successful transition period.
Who to call at VERAXA Biotech, and when
A new leader at VERAXA Biotech brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day VERAXA Biotech raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at VERAXA Biotech, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
VERAXA Biotech
Location
Zurich, Zurich, Switzerland
About
VERAXA Biotech is a Swiss biotechnology company focused on developing innovative oncology therapies. The company specializes in a proprietary BiTAC platform and is advancing various cancer treatment programs. With its recent entry into public markets, VERAXA aims to enhance its product development and market reach.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VERAXA Biotech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ZurichBiotechnologyHealth Care